Implication of the insulin-like growth factor-IR pathway in the resistance of non-small cell lung cancer cells to treatment with gefitinib.

Source:http://linkedlifedata.com/resource/pubmed/id/17473213

Clin. Cancer Res. 2007 May 1 13 9 2795-803

Download in:

View as

General Info

PMID
17473213